– The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy – 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023 SEOUL, South…
Month: February 2024
– The only cuffless blood pressure monitor to complete comparative studies with three types of existing blood pressure measurement methods and prove even accuracy – 24-hour Ambulatory Blood Pressure Monitoring is the first pilot research to reflect ESH recommendations in 2023 SEOUL, South…
MCLEAN, Va., Feb. 14, 2024 /PRNewswire/ — Appian (Nasdaq: APPN) announced today that it is named a Leader in the Everest Group insurance technology report, Low-code Technology Providers in Insurance PEAK Matrix® Assessment 2023. The report analyses 21 low-code insurance providers across…
MCLEAN, Va., Feb. 14, 2024 /PRNewswire/ — Appian (Nasdaq: APPN) announced today that it is named a Leader in the Everest Group insurance technology report, Low-code Technology Providers in Insurance PEAK Matrix® Assessment 2023. The report analyses 21 low-code insurance providers across…
– Das einzige Blutdruckmessgerät ohne Manschette, das Vergleichsstudien mit drei Arten von bestehenden Blutdruckmessmethoden durchgeführt und eine gleichmäßige Genauigkeit nachgewiesen hat – Die ambulante 24-Stunden-Blutdruckmessung ist 2023 die erste Pilotstudie, die die ESH-Empfehlungen…
– Das einzige Blutdruckmessgerät ohne Manschette, das Vergleichsstudien mit drei Arten von bestehenden Blutdruckmessmethoden durchgeführt und eine gleichmäßige Genauigkeit nachgewiesen hat – Die ambulante 24-Stunden-Blutdruckmessung ist 2023 die erste Pilotstudie, die die ESH-Empfehlungen…
STOCKHOLM, Feb. 14, 2024 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its TEAD programme has been selected for a late-breaking presentation at the American Association for Cancer Research’s Annual Meeting 2024. The conference will…
STOCKHOLM, Feb. 14, 2024 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its TEAD programme has been selected for a late-breaking presentation at the American Association for Cancer Research’s Annual Meeting 2024. The conference will…
FläktGroup cierra un año 2023 lleno de éxitos y nombra a Trevor Young como consejero delegado y a Dave Dorney como director de ventas HERNE, Alemania, 14 de febrero de 2024 /PRNewswire/ — FläktGroup, un líder en soluciones de tecnología de aire sostenible, se complace en anunciar los…
STOCKHOLM, Feb. 14, 2024 /PRNewswire/ — Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its TEAD programme has been selected for a late-breaking presentation at the American Association for Cancer Research’s Annual Meeting 2024. The conference will…